Anthera Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jan '26 Jan 23, 2026	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Market Capitalization	0	23	27	185	36	59
Market Cap Growth	-99.64%	-16.09%	-85.28%	410.48%	-38.84%	20.82%
Enterprise Value	-	17	8	129	29	46
Last Close Price	0.00	1.65	5.19	37.12	12.64	24.56
PS Ratio	-	-	187.81	58.09	-	-
PB Ratio	0.00	-4.16	2.12	4.67	-16.03	4.02
P/TBV Ratio	0.00	-	7.06	4.67	-	4.02
EV/Sales Ratio	-	-	54.52	40.58	-	-
Debt / Equity Ratio	-	-	-	-	-	1.21
Asset Turnover	-	-	0.00	0.12	-	-
Quick Ratio	3.06	0.47	1.96	5.58	0.46	3.43
Current Ratio	3.30	0.68	2.14	5.65	0.53	3.48
Return on Equity (ROE)	-568.85%	-731.07%	-211.50%	-188.36%	-473.78%	-549.52%
Return on Assets (ROA)	-141.96%	-167.77%	-99.83%	-85.35%	-86.96%	-55.29%
Return on Capital Employed (ROCE)	-596.90%	3509.80%	-445.10%	-88.90%	1258.70%	-94.60%
Earnings Yield	-952291.83%	-117.60%	-203.88%	-19.04%	-81.68%	-52.07%
FCF Yield	-	-161.47%	-182.44%	-16.75%	-70.63%	-53.87%
Buyback Yield / Dilution	-152.23%	-99.05%	-15.94%	-63.62%	-19.21%	-152.82%

Updated May 15, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.